p|datav0.1news185
HomeMarketsHubsNews185MapMonitor
menu
HomeMarketsHubsNews185MapMonitor
theme
p|data·synced:Polymarket—Kalshi—Manifold—Predict—Myriad—Opinion—Limitless—Gemini—
hubsaboutmethodologyagentsdocsx© 2026
markets·Science and Technology
opentrade on Kalshi ↗
event3 outcomes

When will the FDA approve Intellia Therapeutics' lonvo-z?

Kalshi·Science and Technology·ends Jan 8, 2028
W
vol cum
$1.9k
vol 24h
$0
outcomes
3
ends
Jan 8, 2028
outcomesclick to inspect →
marketselected outcome
Before 2028
rank #1
United States
B
59¢
· 0.0pp
24h change
vol cum
$328
vol 24h
$0
spread
0.09
ends
Jan 8, 2028

If the FDA approves Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema for marketing before Jan 1, 2028, then the market resolves to Yes.

timeline
opened · Mar 24, 2026opencloses · Jan 8, 2028
prices over time · Before 2028 highlighted
−24h
now
volume · by outcomehover a column to inspect
no volume history

similar markets

suggested by pdata
Kalshikalshi
When will Intellia Therapeutics submit a BLA for Lonvo-z?
before April 202774¢· 0.0ppbefore November69¢· 0.0ppbefore 202765¢· 0.0pp
+3 others
$0 24h · 6 markets
Polymarketpolymarket
FDA approves Retatrutide this year?
yes13¢· 0.0pp
$7 24h · 1 market
Manifoldmanifold
Will AOH1996 be FDA approved before 2040?
yes40¢· 0.0pp
M0 24h · 1 market
Kalshikalshi
Will the FDA approve VERVE-102?
Before 203582¢· 0.0ppBefore 203478¢· 0.0ppBefore 203270¢· 0.0pp
+3 others
$0 24h · 6 markets
Polymarketpolymarket
FDA approves Daraxonrasib this year?
yes71¢▲ 0.5pp
$0 24h · 1 market
Manifoldmanifold
The FDA will approve an AI developed cure before the end of the decade (<2030) for a previously incurable major illness.
yes26¢· 0.0pp
M0 24h · 1 market